share_log

424B2: Prospectus

SEC announcement ·  Jul 10 16:08
Summary by Moomoo AI
JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $274,000 Callable Contingent Interest Notes linked to the performance of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index, and the S&P 500 Index, with a maturity date of July 13, 2027. The notes, which are designed for investors seeking contingent interest payments based on the performance of the indices, were priced on July 8, 2024, and are expected to settle on or about July 11, 2024. The notes offer the potential for investors to receive interest payments if the closing level of each index is above 60% of its initial value on any review date. However, investors also bear the risk of losing some or all of their principal if...Show More
JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $274,000 Callable Contingent Interest Notes linked to the performance of the Nasdaq-100 Technology Sector Index, the Russell 2000 Index, and the S&P 500 Index, with a maturity date of July 13, 2027. The notes, which are designed for investors seeking contingent interest payments based on the performance of the indices, were priced on July 8, 2024, and are expected to settle on or about July 11, 2024. The notes offer the potential for investors to receive interest payments if the closing level of each index is above 60% of its initial value on any review date. However, investors also bear the risk of losing some or all of their principal if the indices perform poorly. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, with payments fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes may be redeemed early at JPMorgan's discretion on specified interest payment dates, with the earliest possible redemption date being October 11, 2024. The offering includes a number of risks, as detailed in the 'Risk Factors' section of the accompanying prospectus supplement and product supplement.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more